Skip to main content
. 2023 Nov 27;14:7771. doi: 10.1038/s41467-023-43334-8

Fig. 3. Drug release profiles and bioactive properties of PTK hydrogel.

Fig. 3

a Cumulative TA and KGN release profiles from PTK hydrogel. b Cell viability treated with PMI, PTA, PKG, and PTK hydrogels. c Live/Dead assay of BMSCs incubated with PMI, PTA, PKG, and PTK hydrogels for 24 or 96 h. Scale bar: 200 μm. d Antioxidative efficiency of PTK hydrogel with different concentrations. e In vitro anti-inflammation of PTK hydrogel by IL-6 ELISA test. f Photographs of the survival of E. coli and S. aureus clones after incubation with PBS, KGN, TA, PMI, PKG, PTA, and PTK hydrogels for 12 h. Scale bar: 2 cm. g Quantitative antibacterial efficiency of PBS, KGN, TA, PMI, PKG, PTA, and PTK hydrogels. Values in a, b, d, e, and g represent mean ± SD. One-way ANOVA test. Source data are provided as a Source data file. (n = 3 independent samples. *P < 0.05, **P < 0.01, ***P < 0.001).